UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by GHP Investment Advisors Inc.

GHP Investment Advisors Inc. increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 17,046 shares of the healthcare conglomerate’s stock after acquiring an additional 114 shares during the period. GHP Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $9,966,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group in the third quarter valued at $27,000. Macroview Investment Management LLC grew its holdings in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 47 shares during the period. Delos Wealth Advisors LLC lifted its holdings in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 53 shares during the period. Bbjs Financial Advisors LLC purchased a new stake in UnitedHealth Group in the second quarter valued at approximately $31,000. Finally, Global Wealth Strategies & Associates raised its stake in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $564.56 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $608.63. The firm has a fifty day moving average of $583.52 and a two-hundred day moving average of $537.96. The firm has a market cap of $521.33 billion, a P/E ratio of 36.78, a P/E/G ratio of 1.67 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.56 earnings per share. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.49%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analyst Ratings Changes

UNH has been the topic of several research reports. UBS Group cut their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Robert W. Baird boosted their target price on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. HSBC cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Truist Financial reissued a “buy” rating and issued a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Finally, Argus increased their price target on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.